Completed
A Study of AZD4635 With Durvalumab and With Cabazitaxel and Durvalumab in Patients With mCRPC.
NCT04495179
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
- Locations
-
- Research Site Sacramento, California, United States
- Research Site Tampa, Florida, United States
- Research Site Atlanta, Georgia, United States
- Research Site St Louis, Missouri, United States